Seeing Beyond Anatomy: Quality of Life with Geographic Atrophy
- PMID: 34089491
- PMCID: PMC8319273
- DOI: 10.1007/s40123-021-00352-3
Seeing Beyond Anatomy: Quality of Life with Geographic Atrophy
Abstract
Quality of life (QoL) is a complex idea without a clear consensus definition. Generally speaking, QoL refers to several subjective measures of wellbeing that vary by individual and circumstance. QoL can decline noticeably as a disease progresses. This is particularly true for geographic atrophy (GA), an advanced form of age-related macular degeneration. GA leads to vision loss for which there is no currently approved pharmacological treatment. There is a lack of qualitative, patient-driven research on QoL in GA. There is also limited information available to both patients and physicians about GA, existing support groups and available assistive technologies. To address this, we have collated the experiences of a person with GA and those of her partner and carer with the current literature on QoL in GA. We have also outlined some of the wide range of developing technologies available to help people with GA carry out daily tasks and hobbies. It is clear that support, whether through informal or structured care, is vital to the wellbeing of people with GA. Despite this, the general public are often unaware of care work, which may result in this integral role being undervalued and under acknowledged. Furthermore, it is apparent that the general public have fundamental misunderstandings around what vision loss entails and are unaware that blindness is a vast spectrum. This feeds into the seemingly paradoxical mix of isolation and dependence on others that often results from GA and vision loss. Through this qualitative examination of a patient's experiences, we hope to inform and educate both patients and physicians about GA as well as precipitate discussion around the frameworks that should be in place to support both newly diagnosed and long-term patients with GA and other retinal diseases. Seeing beyond anatomy: quality of life with geographic atrophy (WMV 29479 kb).
Keywords: Age-related macular degeneration; Geographic atrophy; Patient perspective; Qualitative; Quality of life; Retina.
Plain language summary
Asking someone about their ‘quality of life’ is one way to understand their general wellbeing. Quality of life can mean different things to different people. For some people it may mean being able to do what they want to. For others it may include feelings such as happiness. Diseases that cause people to lose their vision can have a very big impact on quality of life. Geographic atrophy is an eye disease that leads to loss of vision and has no cure. In this article, Dolores, a person with geographic atrophy, Bill, her husband and carer, and Jill, a quality of life researcher, discuss how geographic atrophy can change quality of life. Vision loss often means that people are unable to keep up their hobbies and do daily tasks, like shopping or cooking. Learning to use smartphone apps and gadgets can help many people with their hobbies and tasks. Feeling alone also makes quality of life for people with geographic atrophy worse. The help and understanding of others—including friends, family and doctors—are very important. Treatment plans for patients with vision loss need to consider all parts of a patient’s life. Training for doctors should continue to emphasise that people with geographic atrophy are more than just eyes that cannot be treated.
© 2021. The Author(s).
Similar articles
-
Living Without a Diagnosis: A Patient's Perspective on Diabetic Macular Ischemia.Ophthalmol Ther. 2022 Oct;11(5):1617-1628. doi: 10.1007/s40123-022-00546-3. Epub 2022 Jul 12. Ophthalmol Ther. 2022. PMID: 35821381 Free PMC article.
-
The MOSAIC Study: A Mixed-Methods Study of the Clinical, Emotional, and Financial Burden of Geographic Atrophy Among Patients and Caregivers in the US.Clin Ophthalmol. 2024 Aug 23;18:2357-2368. doi: 10.2147/OPTH.S455984. eCollection 2024. Clin Ophthalmol. 2024. PMID: 39193319 Free PMC article.
-
Patient Perspectives in Geographic Atrophy (GA): Exploratory Qualitative Research to Understand the Impact of GA for Patients and Their Families.Br Ir Orthopt J. 2019 Nov 12;15(1):133-141. doi: 10.22599/bioj.137. Br Ir Orthopt J. 2019. PMID: 32999984 Free PMC article.
-
C5 inhibitor avacincaptad pegol treatment for geographic atrophy: A comprehensive review.Immunotherapy. 2024;16(12):779-790. doi: 10.1080/1750743X.2024.2368342. Epub 2024 Jul 29. Immunotherapy. 2024. PMID: 39073397 Free PMC article. Review.
-
Geographic atrophy - Signs, symptoms, and quality of life.Acta Ophthalmol. 2023 Dec;101(8):896-902. doi: 10.1111/aos.15794. Acta Ophthalmol. 2023. PMID: 37933609 Review.
Cited by
-
Integrating Machine Learning and Traditional Survival Analysis to Identify Key Predictors of Foveal Involvement in Geographic Atrophy.Invest Ophthalmol Vis Sci. 2024 May 1;65(5):10. doi: 10.1167/iovs.65.5.10. Invest Ophthalmol Vis Sci. 2024. PMID: 38709525 Free PMC article.
-
Geographic Atrophy Management Consensus (GA-MAC): a Delphi panel study on identification, diagnosis and treatment.BMJ Open Ophthalmol. 2023 Oct;8(1):e001395. doi: 10.1136/bmjophth-2023-001395. BMJ Open Ophthalmol. 2023. PMID: 37857560 Free PMC article.
-
Towards a Therapy for Geographic Atrophy: A Patient's Experience.Patient Prefer Adherence. 2023 Feb 1;17:299-310. doi: 10.2147/PPA.S386662. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 36756537 Free PMC article.
-
The intraocular implant and visual rehabilitation improve the quality of life of elderly patients with geographic atrophy secondary to age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol. 2023 Jan;261(1):263-272. doi: 10.1007/s00417-022-05803-6. Epub 2022 Aug 19. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 35982247 Free PMC article.
-
Living Without a Diagnosis: A Patient's Perspective on Diabetic Macular Ischemia.Ophthalmol Ther. 2022 Oct;11(5):1617-1628. doi: 10.1007/s40123-022-00546-3. Epub 2022 Jul 12. Ophthalmol Ther. 2022. PMID: 35821381 Free PMC article.
References
-
- Barcaccia B, Esposito G, Matarese M, Bertolaso M, Elvira M, De Marinis MG. Defining quality of life: a wild-goose chase? Eur J Psychol. 2013;9:185–203. doi: 10.5964/ejop.v9i1.484. - DOI
-
- WHO. WHOQOL: measuring quality of life. https://www.who.int/mental_health/media/68.pdf. 1997. Accessed 9 Nov 2020.
-
- Karnofsky DA, Burchenal JH. The Clinical Evaluation of Chemotherapeutic Agents in Cancer. In: MacLeod CM, editor, Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949. p. 196.
-
- US Department of Health and Human Sciences, Centers for Disease Control and Prevention. Measuring healthy days: population assessment of health-related quality of life. Atlanta, Georgia: CDC; 2000. Available at: https://www.cdc.gov/hrqol/pdfs/mhd.pdf.
LinkOut - more resources
Full Text Sources